The applicant explained that the study has enrolled 19 study participants with recurrent cubital tunnel syndrome following a failure to maintain the functional improvements from their primary decompression procedure, allowing participants to serve as their own in-patient controls for analysis of the treatment effect of repeating the decompression procedure with the addition of the Axoguard HA+ Nerve Protector TM
PD is well know to affect movement, producing motor symptoms, and also to cause non-motor symptoms, which include autonomic dysfunction, neuropsychiatric problems (mood, cognition, behavior or thought alterations, personality changes, etc.), and sensory and sleep difficulties
This broad anti-inflammatory effect protects multiple retinal cell types simultaneously
Due to its pharmacokinetic properties, clevidipine is hypothesized to quickly achieve and maintain a narrow target BP range
and (4) for Xan with TYR, and possibly (trend) with 5-HIAA
Teo I, Toms SM, Marteyn B, Barata TS, Simpson P, Johnston KA, et al